From animal & cell models to a patient registry, our aim is to equip researchers with the resources to drive the research on #clcn4-condition forward 🔬To this end, we have funded the generation of three CLCN4-rat models, available to researchers via the INFRAFRONTIER repository
Super excited to share the details of Cure CLCN4's Pilot Grant Program! 🙌 Whether you're already involved in research on CLCN4-NDC or are interested in #rarediseases#neurodevelopmentaldisorders and want to join the #clcn4 field, this is a great opportunity!
#cureclcn4
We are thrilled to announce that applications for Cure CLCN4’s Pilot Grant Program are now open!🔬
💰 Award: £150,000 (2-3 grants of £50-75k each).
🚨Deadline: 15th December 2023
For further details and application 👉 https://t.co/etI5XNTbUG
#cureclcn4#clcn4grant#research
We are thrilled to announce that applications for Cure CLCN4’s Pilot Grant Program are now open!🔬
💰 Award: £150,000 (2-3 grants of £50-75k each).
🚨Deadline: 15th December 2023
For further details and application 👉 https://t.co/etI5XNTbUG
#cureclcn4#clcn4grant#research
🚨 Study Alert! The Translational Centre of Research Excellence for Speech Disorders (Australia) has launched an online study on speech & language in CLCN4-related condition. 🌟 Details here: https://t.co/BUJkApKfio
#cureclcn4#clcn4#speech
Symptoms of #CLCN4-NDC: developmental delays, intellectual disability, #seizures, and movement disorders. For more info, check out our website's section for families 👪 https://t.co/gZ4hsqTOla and professionals ��⚕️ https://t.co/PfDgBZzzgT #cureclcn4 #tuesdaytakeover @CureCLCN4
👋 Welcome to @CureCLCN4’s #tuesdaytakeover of @RareRevolutionM! Today, we're shining a spotlight on CLCN4-related neurodevelopmental condition, a rare genetic condition that can cause intellectual disability, seizures, behavioural and movement disorders. https://t.co/TOD016b11v
Only four weeks left to register for in-person attendance at the @CureCLCN4 Scientific Conference 2023, happening on 16th & 17th June! Check out the incredible line-up of speakers that you won't want to miss 🙌 For further details visit our website: https://t.co/p9FPjwYa16
Exciting news! Two #Clcn4 rat models, produced by PHENOMIN-ICS and funded by @CureCLCN4, are now available for research on the #EMMArepository of @InfrafrontierEU🔬! 👉🏻https://t.co/SZdJn4W8xV
Many thanks to families and friends who helped raise the funds to make it possible🙏
We are proud to announce the first Cure CLCN4 webinar, coming in October! 🥳 Stay tuned for details on when and how to watch this episode #cureclcn4#clcn4#specialparenting#webinar
Welcome to the 2022 #EURORDISSummerSchool's 2️⃣8️⃣ participants from 1️⃣8️⃣ countries, and our amazing speakers!
Today we kicked off to a good start with sessions on 🔬therapeutic development in rare diseases, and the methodology and design of clinical trials.
Happy learning to all!
Don't forget to sign up for Cure CLCN4's scientific conference happening on May 27th and 28th! For more details, including the list of speakers and registration details, visit our website: https://t.co/TKMiH0wMbw
#cureclcn4#clcn4#raredisease#ionchannel